Intensive treatment in order to minimize the Ph-positive clone in CML

Bone Marrow Transplantation

Volumn 17, Issue SUPPL. 3, 1996, Pages

  Simonsson, B ^a   Oberg G ^a   Bjoreman M ^b   Bjorkholm M ^c   Carneskog, J ^d   Gahrton, G ^c   Hast, R ^e   Karl, H ^l   Lanng Nielsen, J ^f   Lofvenberg E ^g   Malm, C ^h   Turesson, I ⁱ   Uden A M ^j   Vilen L ^d   Weis Bjerrum, O ^k  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e DANDERYD HOSPITAL   (Sweden)

^f Amtssygehuset   (Denmark)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j STOCKHOLM SÖDER HOSPITAL   (Sweden)

^k University of Copenhagen   (Denmark)

^l GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Autologous transplantation; Chronic myelogenous leukaemia; Treatment

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CYTOGENETICS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DENMARK; FEMALE; HUMANS; HYDROXYUREA; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; SWEDEN; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 15844363625     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Hughes TP, Brito-Babapulle F, Tollit DJ et al. Induction of Philadelphia-negative hemopoiesis and prolongation of chronic phase in patients with chronic myeloid leukemia treated with high dose chemotherapy and transfusion of peripheral blood stem cells. In: Dicke KA, Armitage JO, Dicke-Ewinger MJ (eds). Autologous Bone Marrow Transplantation (Proceedings of the 5th International Symposium). University of Nebraska Medical Center, USA, 1991.
2. McGlave PB, De Fabritiis P, Deisseroth A et al. Autologous transplant therapy for chronic myelogenous leukemia prolongs survival. Results from eight transplant groups. Lancet 1994; 343: 1486-1488.
3. De Fabritiis P, Sandrelli A, Meloni G et al. Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant 1990; 6: 247-251.
4. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood 1993; 82: 691-703.
5. Goto T, Nishikorin AZ. Growth characteristics of leukemia and normal hematopoietic cells in Ph + chronic myelogenous leukemia and effects of intensive treatment. Blood 1982; 59: 793-803.